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Endothelial cells use dynamic actin to facilitate 
lymphocyte transendothelial migration and 
maintain the monolayer barrier
Olivia L. Mooren, Jinmei Li, Julie Nawas, and John A. Cooper
Department of Cell Biology and Physiology, Washington University, St. Louis, MO 63110
ABSTRACT The vascular endothelium is a highly dynamic structure, and the integrity of its 
barrier function is tightly regulated. Normally impenetrable to cells, the endothelium actively 
assists lymphocytes to exit the bloodstream during inflammation. The actin cytoskeleton of 
the endothelial cell (EC) is known to facilitate transmigration, but the cellular and molecular 
mechanisms are not well understood. Here we report that actin assembly in the EC, induced 
by Arp2/3 complex under control of WAVE2, is important for several steps in the process of 
transmigration. To begin transmigration, ECs deploy actin-based membrane protrusions that 
create a cup-shaped docking structure for the lymphocyte. We found that docking structure 
formation involves the localization and activation of Arp2/3 complex by WAVE2. The next 
step in transmigration is creation of a migratory pore, and we found that endothelial WAVE2 
is needed for lymphocytes to follow a transcellular route through an EC. Later, ECs use actin-
based protrusions to close the gap behind the lymphocyte, which we discovered is also 
driven by WAVE2. Finally, we found that ECs in resting endothelial monolayers use lamellipo-
dial protrusions dependent on WAVE2 to form and maintain contacts and junctions between 
cells.
INTRODUCTION
Endothelial cells (ECs) have critical roles in the immune and vascular 
systems. First, they establish and maintain the barrier between the 
blood stream and the underlying tissues. Second, they facilitate the 
migration of leukocytes from the blood into the tissue. Both func-
tions are highly dynamic and regulated. During inflammation, the 
barrier opens in a regulated manner to allow for the passage of flu-
ids, cytokines, and leukocytes. Dysfunction of the endothelial barrier 
is a prominent component of many disease states, including athero-
sclerosis, chronic inflammation, and diabetes (Weber et al., 2007; 
Dejana et al., 2008; Bakker et al., 2009; Kumar et al., 2009; Sima 
et al., 2009; Rigor et al., 2013).
Transendothelial migration (TEM), or diapedesis, is the process 
by which leukocytes cross from the bloodstream into the underlying 
tissue. ECs actively participate in this process, interacting with the 
migrating leukocytes in a complex network of cross-signaling be-
tween the cells (Wittchen, 2009; Nourshargh et al., 2010). Signaling 
networks in both cells orchestrate complex dynamic changes in the 
actin cytoskeleton (Barreiro et al., 2004; Nourshargh et al., 2010), 
which control the shape of the cells and generate the forces that 
move the leukocyte across the endothelium. The molecular mecha-
nisms for movement by leukocytes have been relatively well stud-
ied, but much less is known about the mechanisms by which ECs 
enable and promote leukocyte transmigration.
The first step in TEM is formation of a protrusive docking struc-
ture on the surface of the EC, which cups the leukocytes. The sec-
ond step is formation of a transmigratory pore, either within one EC 
(the “transcellular” route) or between two ECs (the “paracellular” 
route). The final step is closure of the pore after the leukocytes com-
pletely transits across the monolayer.
For the paracellular migration route, leukocytes bind to cell junc-
tion proteins, such as PECAM, CD99, and JAMs (Muller et al., 1993; 
Ostermann et al., 2002; Schenkel et al., 2002; Bradfield et al., 2007; 
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RESULTS
To begin TEM, lymphocytes adhere to the endothelial monolayer 
and walk along its apical surface (Supplemental Movie S1 and Figure 
1A). Docking structures form on the EC and bind the lymphocyte, 
after which the lymphocyte passes through the endothelium via the 
paracellular or transcellular route. Supplemental Movie S1 and 
Figure 1A show an example of the latter.
Docking structure formation: roles of WAVE2 and Arp2/3
The docking structure is an actin-rich membrane protrusion, which 
forms on the surface of the EC as the leukocyte comes in contact 
(Barreiro et al., 2002; Carman et al., 2003; Carman and Springer, 
2004). The docking structure promotes the physical interaction be-
tween the two cells, and it serves as a hub for generation and regu-
lation of signals that drive the subsequent processes of transmigra-
tion in both ECs and leukocytes.
We hypothesized that WAVE2 might function in docking struc-
ture formation to recruit and activate Arp2/3 complex and induce 
the actin assembly that drives protrusions. To test this hypothesis, 
we induced docking structures to form on ECs in monolayers us-
ing polystyrene beads coated with anti–ICAM-1 instead of lym-
phocytes. The anti–ICAM-1 on the bead clusters the integrin re-
ceptor ICAM-1 on the surface of the EC (Tilghman and Hoover, 
2002; van Buul et al., 2007; van Rijssel et al., 2012), mimicking the 
action of LFA-1 on the lymphocyte (van Buul et al., 2007). The 
docking structures induced by anti–ICAM-1–coated beads resem-
ble those induced by lymphocytes in terms of morphology and 
molecular composition. The use of beads allows one to focus ex-
clusively on endogenous components of the EC, avoiding signals 
from lymphocytes.
Using immunofluorescence, we observed endogenous Arp2/3 
complex, WAVE2, and F-actin on EC docking structures created by 
anti–ICAM-1 beads (Figure 1B). ICAM-1 clustered around most 
beads, and nearly every ICAM-1–positive bead recruited WAVE2, 
Arp2/3 complex, and F-actin, which appeared as rings around the 
beads. If beads did not cluster ICAM-1, they did not recruit WAVE2, 
Arp2/3 complex, or F-actin. We conclude that ICAM-1 clustering is 
necessary and sufficient for recruitment of WAVE2, Arp2/3, complex 
and F-actin and that the process of docking structure assembly is 
robust.
We assessed the role of WAVE2 in docking structure formation 
by depleting WAVE2 with small interfering (siRNA). We chose an 
oligonucleotide that decreased WAVE2 protein levels (see Materials 
and Methods and Supplemental Figure S1A), and we documented 
specificity by rescue with expression of siRNA-resistant WAVE2. 
Anti–ICAM-1 beads adhered to WAVE2-depleted cells to a similar 
extent as observed for control cells; however, the recruitment of 
Arp2/3 complex and F-actin was decreased (Figure 1C). For Arp2/3 
complex, 15.5 ± 5.7% (median ± SE of proportion [SEp], N = 40 
fields of view [fov]) of beads stained for Arp2/3 complex in WAVE2-
depleted monolayers, compared with 34.6 ± 7.5% (N = 40 fov) in 
control monolayers. For F-actin, 9.0 ± 5.2% (median ± SEp, N = 30 
fov) of beads stained for F-actin in WAVE2-depleted monolayers, 
compared with 33.7 ± 8.6% (N = 30 fov) in controls (Figure 1D).
The defect in recruitment of F-actin was more prominent than 
the defect in recruiting Arp2/3 complex. In control cells, only 
3.5 ± 0.6% (mean ± SEp, N = 857 rings) of bead-associated rings 
that were positive for Arp2/3 complex did not stain for F-actin. In 
contrast, in WAVE2-depleted cells, 33.4 ± 1.9% (N = 619 rings) of 
Arp2/3-positive rings did not stain for F-actin. We conclude that 
WAVE2 both recruits and activates Arp2/3 complex in the EC in or-
der to induce actin assembly and generate docking structures.
move through loosened cell–cell junctions. In the transcellular mi-
gration route, leukocytes pass through a transcellular channel cre-
ated by the EC. Transcellular migration involves integrin-based in-
teractions between the leukocyte and the EC, along with junctional 
proteins between ECs, which redistribute during transmigration 
(Carman et al., 2007; Carman and Springer, 2008; Mamdouh et al., 
2009).
Rho GTPases are critical components of the EC signaling path-
ways that control cell junctions (Aghajanian et al., 2008; Wittchen, 
2009; Daniel and van Buul, 2013). Signals are generated by solu-
ble inflammatory mediators, such as tumor necrosis factor α 
(TNFα), and by cell-surface adhesion molecules, such as intercel-
lular adhesion molecule 1 (ICAM-1; Stolpen et al., 1986; Clark 
et al., 2007; Muller, 2009). These primary signals activate Rac1 and 
RhoA in the EC, leading to controlled perturbations in the mono-
layer (Wojciak-Stothard et al., 1998; Wojciak-Stothard and Ridley, 
2002; van Wetering et al., 2002; Nwariaku et al., 2003) and actions 
that facilitate leukocyte transmigration (van Wetering et al., 2003; 
Wittchen, 2009; Daniel and van Buul, 2013). Rac1 and RhoG pro-
mote formation of the actin-based, cup-shaped structure that 
docks the transmigrating leukocyte (van Buul et al., 2007; van Rijs-
sel et al., 2012) and also coordinates downstream signaling. Cort-
actin in endothelial cells has been shown to play a critical role in 
many steps during transmigration (Tilghman and Hoover, 2002; 
Yang et al., 2006a,b). However, nothing is known about other 
Arp2/3 complex regulators downstream of Rac, and little is known 
about the how Arp2/3 complex contributes to the various steps 
during transmigration.
Martinelli et al. (2013) described roles for Rac1 and Arp2/3 com-
plex in pore closure after transmigration of T-lymphocytes. They 
found that ECs use directional lamellipodial protrusions to close 
lymphocyte transmigration pores. They concluded that Rac1 activa-
tion promoted the formation of these lamellipodia, based on effects 
of the Rac1 inhibitor NSC23766 and by overexpression of dominant-
negative Rac1. They also used an inhibitor of Arp2/3 complex, CK-
666, to demonstrate that these lamellipodia depended on the activ-
ity of Arp2/3 complex.
Rac1 has several downstream effectors other than Arp2/3 com-
plex, and a number of proteins are able to recruit and activate 
Arp2/3 complex; therefore we chose to focus on the role of the 
specific effector WAVE2, and we used molecular genetic approaches 
specific for WAVE2. Rac1 recruits and activates WAVE2 at locations 
where formation of Arp2/3-mediated dendritic actin networks are 
required. WAVE2 is one subunit of a pentameric protein complex 
that promotes actin nucleation by Arp2/3 complex (Ibarra et al., 
2005; Campellone and Welch, 2010; Derivery and Gautreau, 2010). 
In ECs, WAVE2 is known to be important for lamellipodia formation 
(Yan et al., 2003; Yamazaki et al., 2005, 2007; Bryce et al., 2013) and 
for directed cell migration (Yamazaki et al., 2003).
In this study, we asked how Arp2/3 complex–dependent F-actin 
networks contribute to transmigration at each step of the process. 
We used perturbation of WAVE2 to provide insight into the role of 
Arp2/3 complex during transmigration. We analyzed the dynamics 
of living ECs and lymphocytes in a primary-cell culture system using 
time-lapse movies, fluorescent fusion proteins, and RNA interfer-
ence–mediated gene targeting. We found that actin assembly 
downstream of WAVE2 in ECs is necessary to engage transmigrat-
ing lymphocytes, promote the transcellular route of migration, and 
close junctional pores after the lymphocyte moves away. We also 
found that WAVE2 is necessary for endothelial monolayer integrity, 
which is a critical determinant of overall transendothelial migration, 
especially the paracellular route.
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For the paracellular route, PBLs migrated over the course of 
2–5 min through a pore that formed between two ECs. The pore 
often remained open for several minutes after the PBL moved 
away from the transmigration site (Figure 2A; asterisk indicates a 
persisting pore). WAVE2-GFP did not accumulate at the transmi-
gration site either before or during transmigration (Figure 2A and 
Supplemental Movie S2). When the pores closed, if the pore size 
was large, ECs produced waves of membrane protrusion as they 
Recruitment of WAVE2 during transmigration 
of lymphocytes
After docking structures form, lymphocytes traverse the monolayer 
by migrating between cells (paracellular route) or through individual 
ECs (transcellular route). For both routes, we observed recruitment 
of WAVE2–green fluorescent protein (GFP) in the EC to the site of 
transmigration by peripheral blood lymphocytes (PBLs) at distinct 
times during the process.
FIGURE 1: WAVE2 and Arp2/3 complex are important for docking structure formation. (A) Frames from Supplemental 
Movie S1 show a lymphocyte undergoing transcellular transmigration through an EC expressing membrane-tagged GFP. 
Scale bar, 10 μm. (B) WAVE2, Arp2/3 complex, and F-actin colocalize with rings of ICAM-1 that form around anti–ICAM-
1–coated beads in contact with ECs after 30 min of incubation. The yz- and xz-projections from three-dimensional (3D) 
data sets reveal membrane protrusions extending upward to cup the beads. Scale bar, 20 μm. (C) WAVE2 depletion 
decreases the number of bead-associated rings stained for F-actin and Arp2/3 complex. Red arrows indicate rings of 
F-actin and Arp2/3 complex around anti-ICAM-1 beads. Scale bar, 50 μm. (D) WAVE2 depletion decreases the number 
of beads with associated rings of F-actin and Arp2/3 complex. Beads and positive-stained rings were counted in 10 fov 
for three separate experiments (N = 30). Box-and-whisker plots show median, interquartile range, and extremes.
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FIGURE 2: WAVE2 localization to membrane protrusions that close gaps and form at sites of transcellular pores. 
(A) WAVE2 is not recruited to paracellular pores during PBL transmigration. Frames from Supplemental Movie S2. 
Asterisk indicates a gap between ECs that persists after transmigration. Scale bar, 3 μm. (B) WAVE2 localizes to 
endothelial monolayer gaps that close after lymphocyte transmigration. Frames from Supplemental Movie S3. Asterisks 
indicate the gap, which closes after a wave of membrane protrusion. Red arrows indicate membrane waves, where 
WAVE2 has accumulated. Scale bar, 3 μm. (C) WAVE2 localizes to docking structures at sites of transcellular migration. 
ECs expressing WAVE2-GFP and immunolabeled for ICAM-1. Transmigrating lymphocyte is shown in the DIC image. 
The yz- and xz-projections from a 3D data set reveal WAVE2 in membrane protrusions that cup the PBL.
closed the gap. WAVE2-GFP localized at the front of these pro-
trusions, which traveled laterally along the edge of the EC (Figure 
2B and Supplemental Movie S3). This dynamic behavior is con-
sistent with the idea that WAVE2 activates Arp2/3 complex and 
promotes actin assembly to drive the formation and extension of 
membrane protrusions. Small pores sometimes closed rapidly, 
without membrane protrusions, and WAVE2-GFP did not 
accumulate.
The transcellular route occurred less frequently in cells express-
ing WAVE2-GFP, and the degree of inhibition appeared to be pro-
portional to the expression level, so we suspect that the expression 
had a dominant negative effect. This effect limited the number of 
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filter separating the upper and lower chambers. We measured the 
number of PBLs that migrated from the upper to the lower chamber. 
WAVE2 depletion increased the number of PBLs that transmigrated 
(Figure 3C). However, the level of variation between experiments was 
large with this assay; in some cases, the number of transmigrating 
PBLs did not change or decreased. We speculate that this high level 
of variance in the assay resulted from variations in the morphology of 
the EC monolayer caused by WAVE2 depletion, which was associ-
ated with gaps between ECs of variable number and size. The effect 
of WAVE2 depletion on EC monolayer morphology is discussed in 
more detail later. Expression of siRNA-resistant WAVE2 restored PBL 
transmigration to levels similar to that in control endothelial monolay-
ers (Figure 3C).
To address the role of WAVE2 in TEM with a quantitative assay 
that would not depend so highly on gaps in the monolayer, we used 
a different approach. We fixed TEM preparations and stained them 
with anti–VE-cadherin to reveal EC junctions, anti–ICAM-1 to reveal 
transendothelial pores, and fluorescent phalloidin to visualize 
transcellular-route events available for movie analysis. As an alterna-
tive approach, we used fixed and stained preparations, which al-
lowed us to examine many large fields of view in order to visualize a 
sufficient number of events. Fluorescence imaging of anti–ICAM-1 
and WAVE2-GFP revealed that WAVE2 was recruited to sites of tran-
scellular TEM in ECs (Figure 2C). Accumulation of WAVE2 was great-
est at early stages of transcellular TEM, such as during docking 
structure formation, with lesser amounts of WAVE2 observed at later 
stages, when PBL migration through the pore was near completion. 
In these fixed preparations, identification of pores in the process of 
closing is problematic because PBLs often migrate away from the 
pore before closure. Therefore we were not able to assess WAVE2 
recruitment to sites of transcellular pore closure.
Relative importance of WAVE2 in transcellular 
and paracellular routes
To quantitate the effect on WAVE2 depletion on TEM, we first used a 
conventional Transwell assay with an endothelial monolayer on the 
FIGURE 3: WAVE2 is important for the transcellular route of lymphocyte transmigration and bulk migration of 
lymphocytes across endothelial monolayers. (A) Representative images illustrating the transcellular route (red) and 
paracellular route (blue). An endothelial monolayer with transmigrating lymphocytes was stained for ICAM-1, VE-
cadherin, and F-actin. (B) Quantification of the routes of transmigration by lymphocytes (PBLs). The percentage of total 
PBLs that transmigrate by the paracellular or the transcellular route was calculated. Data from experiments on three 
separate days are combined and plotted as the mean and SE of proportion (control EC monolayers, N = 3330 PBLs; 
WAVE2-knockdown EC monolayers, N = 2167 PBLs). (C) WAVE2-knockdown endothelial monolayers show increased 
transendothelial migration by lymphocytes in Transwell assays. Box-and-whisker plots show the median, the interquartile 
range, and the extremes of the number of transmigrated cells (N = 14).
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wide range of individual morphologies. Many were rounded up and 
no longer in contact with their neighbors. In movies, these cells were 
often blebbing very actively, and they made frequent attempts to 
spread back down onto the surface (Supplemental Movie S4). Scor-
ing cells on their morphology, we found that WAVE2-depleted 
monolayers had 34.7 ± 23.8% (mean ± SEp, 814 cells, four movies) 
rounded-up or blebbing cells, whereas control monolayers had only 
0.20% ± 1.99% (968 cells, five movies). This difference was statisti-
cally significant, with p < 0.01. Expression of siRNA-resistant WAVE2-
GFP rescued this phenotype, leading to nearly complete absence of 
cells with the rounded-up and blebbing morphology (1.8 ± 0.8%, 
402 cells, three movies; Supplemental Movie S6). The p value for 
control versus WAVE2 rescue was 0.13.
Movie analysis also revealed that addition of PBLs to control EC 
monolayers often caused effects at contacts between EC neighbors, 
even when PBLs were located at a distance. These effects consisted 
of dynamic ruffling at cell–cell junctions, along with the occasional 
formation of small gaps as cells pulled away from one another while 
ruffling (Supplemental Movie S5 and Figure 4). When such a gap 
appeared, lamellipodial protrusions formed quickly and closed the 
gap. In WAVE2-depleted monolayers, the number of gaps was high, 
as noted earlier, and there were fewer lamellipodial protrusions that 
closed gaps between cells than with control monolayers.
On the basis of these observations of EC monolayers, we hy-
pothesized that WAVE2 depletion might cause defects in the overall 
integrity of the endothelial barrier measured by conventional physi-
ological assays. To test this hypothesis, we first measured electrical 
resistance across the monolayer (transendothelial resistance [TER]; 
Figure 5A). WAVE2 depletion caused TER to decrease to levels simi-
lar to those caused by chelation of Ca2+, which completely disrupts 
cadherin-based cell–cell junctions. Depolymerizing actin with latrun-
culin A (LatA) also decreased TER by a large amount (Figure 5A) and 
created large gaps between ECs (Supplemental Figure S1B), consis-
tent with previous findings (Prasain and Stevens, 2009). Second, we 
migrating PBLs (Figure 3A). This approach allows one to identify 
paracellular-route and transcellular-route sites of TEM with certainty. 
Paracellular-route sites were defined by PBLs at cell junctions, inter-
calated between two adjacent ECs, which were not otherwise sepa-
rated by a gap. Transcellular-route sites were defined by PBLs at 
pores in the central region of an EC that was fully spread and in 
contact with its neighbors in the monolayer.
Using this approach, we found that depletion of WAVE2 from EC 
monolayers decreased the frequency of transcellular TEM events to 
51% of the value seen with control EC monolayers; the difference 
was highly significant (p < 0.001; Figure 3B). In contrast, the fre-
quency of paracellular TEM events did not change (Figure 3B). Thus 
WAVE2 is more important for the transcellular route than the para-
cellular route. Using these fixed and stained preparations, we mea-
sured the dimensions of the pores for transcellular-route events in 
the x-y plane and found no difference between control and WAVE2-
depleted cells. The area of the pores was 37.3 ± 7.7 μm2 (mean ± SE, 
N = 12) for control cells and 37.6 ± 6.9 μm2 (N = 8) for WAVE2-de-
pleted cells. We conclude that WAVE2 is important for transcellular-
route events to occur, but that when the events do occur, the pores 
have a normal size, which is presumably determined by the size of 
the migrating cells. For the paracellular route, measuring pore di-
mensions was confounded by the many gaps between ECs in 
WAVE2-depleted monolayers. Finally, we attempted to examine the 
dynamics of transcellular pore formation and closure using movies 
of living cell movies, but the number of transcellular-route events in 
WAVE2-depleted monolayers was too small to allow meaningful 
conclusions.
WAVE2 is important for integrity of the endothelial 
monolayer
As noted earlier, we observed many intercellular gaps in WAVE2-
depleted monolayers (Supplemental Movie S4 and Figure 4). Cells 
within WAVE2-depleted endothelial monolayers also displayed a 
FIGURE 4: WAVE2 is necessary for limiting gaps and promoting spread-cell morphology in endothelial-cell monolayers. 
Images are frames from movies, with control from Supplemental Movie S5 and WAVE2 KD (knockdown) from 
Supplemental Movie S4. Scale bar, 100 μm.
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acetic acid (EGTA). The effect of WAVE2 depletion was also rela-
tively large, and the addition of TNFα had little to no further effect. 
Similar results were seen using the fluorescent dextran permeabil-
ity assay (Supplemental Figure S1C). Together the results indicate 
that WAVE2 depletion results in an essentially complete loss of 
endothelial monolayer integrity, in excess of the effect caused by 
TNFα.
How might WAVE2 contribute to endothelial monolayer integ-
rity? We reasoned that WAVE2 might localize to cell edges and ac-
tivate Arp2/3 complex, causing protrusions that initiate contacts 
between cells as a prelude to cell–cell junction formation. Lamelli-
podial protrusions have been implicated in the formation of junc-
tions between epithelial cells (Adams et al., 1996), and lamellipodia 
measured the permeability of the monolayer to fluorescent dextran, 
as an indicator of barrier integrity. Again, EC monolayers depleted 
of WAVE2 showed increased permeability compared with control 
(Supplemental Figure S1C).
In our experiments, the endothelial monolayers were generally 
treated with the proinflammatory molecule TNFα in order to mimic 
inflammatory conditions and promote interaction of ECs with PBLs. 
Inflammation increases vascular permeability, so we asked whether 
TNFα alone would affect barrier integrity in these assays. In control 
cells, TER decreased with TNFα treatment (Figure 5A), as expected 
(Blum et al., 1997; Nwariaku et al., 2003; Clark et al., 2007). Quan-
titatively, the effect of TNFα on control monolayers was modest 
compared with the large effect of LatA or ethylene glycol tetra-
FIGURE 5: WAVE2 maintains endothelial monolayer integrity by promoting Arp2/3-based lamellipodial protrusions. 
(A) Electrical resistance across monolayers, plotted as a normalized index for TER (see Materials and Methods). Data are 
derived from experiments on three or more days, with three or more repetitions on each day. Plotted values are the 
mean of all the data points, and error bars are SD (N ≥ 9). (B) Localization of WAVE2 and Arp2/3 complex adjacent to 
cell–cell junctions, based on immunofluorescence and fluorescent phalloidin staining of endothelial monolayers. Arrows 
indicate localization close to but not coincident with cell junctions. Scale bar, 50 μm. (C) Magnified views of boxed 
regions in B. Line scans across cell–cell junctions (blue box) or along junctions (magenta box). Scale bar, 20 μm. 
(D) Localization of Arp2/3 complex and WAVE2 at cell–cell junctions formed in response to S1P. Merge, green is 
anti-Arp3 or anti-WAVE2; red is VE-cadherin. Top, control; bottom, with S1P added. Scale bar, 50 μm; inset, 20 μm.
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Second, movies revealed that dynamic 
lamellar and lamellipodial protrusions 
formed along the cell periphery and in the 
vicinity of cell–cell junctions (Supplemental 
Movie S7). These protrusions contained 
WAVE2 at their leading edge (Supplemen-
tal Movie S8), which supports the idea that 
WAVE2 and Arp2/3 complex drive actin as-
sembly in order to promote formation of 
cell junctions and repair gaps between cells. 
Consistent with this notion, Taha et al. (2014) 
used chemical inhibitors of Arp2/3 complex 
to demonstrate that Arp2/3-based lamelli-
podial protrusions exist and are important 
to maintain the endothelial monolayer.
To test this hypothesis further, we in-
creased the number of membrane protru-
sions by treating endothelial monolayers 
with sphingosine-1-phosphate (S1P; Supple-
mental Figure S2). Ruffling lamellipodia and 
lamellar protrusions induced by S1P con-
tained WAVE2 and Arp2/3 complex (Figure 
5D). VE-cadherin did not colocalize with 
Arp2/3 or WAVE2, indicating that WAVE2 
and Arp2/3 complex promote lamellipodial 
protrusions before the recruitment of VE-
cadherin to nascent cell–cell junctions.
Molecular basis for loss of monolayer 
integrity on WAVE2 depletion
To investigate the molecular basis for the 
loss of monolayer integrity upon deple-
tion of WAVE2, we examined the mole-
cular composition of cell contacts and 
cell–cell junctions using immunofluores-
cence. In control monolayers, VE-cadherin 
was predominantly organized in a pattern 
typical for mature junctions—continuous 
linear structures coinciding with cell–cell 
contacts (Figure 6A). In contrast, WAVE-
depleted monolayers showed very few 
VE-cadherin–positive cell junctions (Figure 
6A). The number of gaps in the junctions 
increased from 3.0 ± 1.0/fov (mean ± SD, 
N = 6 fov) in control monolayers to 11.2 ± 
2.3/fov in WAVE2-knockdown monolay-
ers. This difference was statistically signifi-
cant, with p < 0.001.
We quantitated the level of VE-cadherin at cell junctions in the 
immunofluorescence images. In control cells, the level of anti–VE-
cadherin fluorescence intensity was 37.9 ± 2.6 arbitrary units (A.U.) 
per junction (median ± SE, N = 126 junctions from 6 fov). In WAVE2-
depleted cells, for the cell junctions that were present, the anti–VE-
cadherin fluorescence intensity was 12.6 ± 3.7 A.U. (median ± SE, 
N = 99 junctions from 6 fov). This difference was also highly statisti-
cally significant, p < 0.001. In addition, immunoblot analysis re-
vealed that the total level of VE-cadherin expression was decreased 
in WAVE2-depleted ECs (25.6 ± 0.2%, mean ± SEp, N = 4, p = 0.01) 
compared with control cells (Figure 6B).
In contrast, a similar analysis of the tight junction component 
ZO-1 showed little to no change upon depletion of WAVE2. Quali-
tatively, by immunofluorescence, ZO-1 was readily observed at 
have been observed during initial formation of cell–cell contacts 
between ECs (Hoelzle and Svitkina, 2012). Information about the 
molecular components that establish junctions or maintain junc-
tional integrity of ECs is lacking, but the Arp2/3 complex has been 
implicated in maintaining intact endothelial monolayers (Taha et al., 
2014).
First, we found that WAVE2 was localized near or next to cell 
junctions between ECs but not coincident with junctions in fixed and 
stained preparations (Figure 5, B and C). Line scans of fluorescence 
intensity across or along junctions demonstrated that VE-cadherin 
and WAVE2 were frequently adjacent to, but infrequently coincident 
with, each other (Figure 5C). The localization of Arp2/3 complex 
around cell junctions was similar to that of WAVE2 (Figure 5B), con-
sistent with a recent report (Taha et al., 2014).
FIGURE 6: WAVE2 promotes VE-cadherin expression and maturation of cell–cell junctions. 
(A) WAVE2-knockdown monolayers have large gaps between cells, outlined in yellow, and the 
intensity of VE-cadherin staining is substantially decreased. Scale bar, 50 μm. (B) Decreased total 
VE-cadherin in WAVE2-knockdown monolayers, by immunoblot. (C) Depletion of WAVE2 leads 
to a change from mature junctions, collinear with the cell edge, to immature junctions 
perpendicular to the cell edge, based on staining for VE-cadherin and vinculin. Scale bar, 50 μm.
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organized; the formation and function of this structure in ECs 
have not been studied.
Many WAVE2-depleted cells displayed rounded-up and bleb-
bing morphologies, as noted earlier. These cells did not contain ei-
ther circumferential F-actin or stress fibers (Supplemental Figure 
S5A, red stars). Therefore, for this analysis, we focused on cells that 
were in a monolayer and fully spread. We observed that the fluores-
cence intensity of myosin-II and F-actin in circumferential F-actin fi-
bers in such cells was increased in WAVE2-depleted endothelial 
monolayers compared with control-cell monolayers (Figure 8, A and 
B). This finding suggests that increased tension from circumferential 
actin causes WAVE2-depleted cells to round up.
If this hypothesis is correct, then one would expect increased 
tension to result in decreased area in well-spread cells in WAVE2-
depleted monolayers. As expected, the area of well-spread cells in 
WAVE2-knockdown monolayers was smaller (1980.8 ± 92.2 μm2, 
mean ± SE, N = 99) than that of control cells (2430.2 ± 116.7 μm2, 
N = 71). The difference was statistically significant, with p = 0.003.
However, we found that the total levels of F-actin and myosin-II 
were not affected by WAVE2 depletion. The total level of myosin-IIA 
fluorescence staining per cell was similar for WAVE2-knockdown 
and control monolayers, with intensity values of 6.0 × 106 ± 3.3 × 106 
A.U. (median ± SD, N = 99 cells) and 5.6 × 106 ± 4.1 × 106 A.U. 
(N = 71 cells), respectively (p = 0.9). The level of F-actin, determined 
by immunoblots of detergent-resistant cytoskeletons (see Materials 
and Methods), was also similar in WAVE2-knockdown and control 
cells (Supplemental Figure S5B).
Considering these results together, we suggest that depletion of 
WAVE2 shifts F-actin and myosin-II into the circumferential F-actin 
fiber pool, which increases tension. Increased tension, in turn, de-
creases cell size and increases the likelihood that cell lose contact 
and round up.
Previous studies of endothelial monolayers found that inflamma-
tory conditions lead to loss of monolayer integrity, in association 
with decreased circumferential actin and increased stress fibers 
(Stolpen et al., 1986; Blum et al., 1997; Clark et al., 2007). First, we 
confirmed these results in our preparations; control-cell monolayers 
treated with TNFα showed loss of circumferential actin with in-
creased stress fibers (Figure 8C, left, arrows, and right, arrows). Next 
we observed that depletion of WAVE2 prevented these TNFα-
induced changes. Circumferential actin staining was increased, not 
decreased, and stress fibers did not increase (Figure 8C). Thus the 
inflammatory effects of TNFα require the presence of WAVE2, pre-
sumably due to effects on dynamic actin assembly.
Overall our results show that WAVE2 enhances the assembly 
and influences the organization of circumferential actin fibers. We 
also conclude that WAVE2 is important for the reorganization of 
fibers under inflammatory conditions, most likely by an indirect 
mechanism.
DISCUSSION
The most important finding of our study is that ECs use WAVE2 to 
create Arp2/3-based actin filament networks necessary for lympho-
cyte transmigration. EC WAVE2 appears to activate Arp2/3 complex 
and thereby promote actin assembly at the docking structures that 
bind lymphocytes to the EC. We also found a role for WAVE2 and 
Arp2/3 complex in generating lamellipodial protrusions that con-
tribute to the integrity of EC monolayers by closing gaps caused by 
inflammatory conditions or transmigrating lymphocytes. Our results 
provide insight into the tissue-level mechanisms by which the vascu-
lar endothelium maintains a dynamic barrier and selectively orches-
trates transmigration during inflammation.
persisting junctions in WAVE2-depleted cells, with a pattern and 
intensity similar to those of control cells (Supplemental Figure 
S3A). Immunoblots revealed only a small decrease of ZO-1 protein 
expression; the level in WAVE2-depleted cells was 88% (average 
of two experiments) of the level in control cells (Supplemental 
Figure S3B).
The junctions that were present in WAVE2-depleted monolayers 
appeared to be immature, based on morphology and vinculin con-
tent (Figure 6C). Mature cell–cell junctions in control EC monolay-
ers, defined by linear anti–VE-cadherin staining coincident with cell–
cell contacts, displayed a low level of anti-vinculin staining (Figure 
6C, top). In control monolayers, vinculin was also present at focal 
contacts, which are cell–substrate junctions devoid of VE-cadherin 
(Figure 6, C and inset). In WAVE2-depleted monolayers, the VE-
cadherin at persisting junctions was organized as short, linear struc-
tures oriented perpendicular to the cell edge (Figure 6, C and inset), 
characteristic of immature cell–cell junctions (Heyraud et al., 2008; 
Huveneers et al., 2012). In a quantitative analysis, the number of 
mature junctions decreased from 8.7 ± 2.9/fov in control monolayers 
to 2.7 ± 0.8/fov in WAVE2-depleted monolayers (mean ± SD, N = 6 
fov; p < 0.001).
Functional ability of WAVE2-depleted ECs to form 
cell–cell junctions
To investigate further the role of WAVE2 in cell junction formation, 
we challenged EC monolayers to assemble junctions by Ca2+ deple-
tion and addition (Figure 7, Supplemental Figure S4, and Table 1). 
VE-cadherin–based junctions are lost when Ca2+ is removed, and 
they assemble when Ca2+ is added back. We found that depletion 
of WAVE2 impaired the efficiency of ECs to form cell junctions in this 
assay (Figure 7, Supplemental Figure S4, and Table 1). At all time 
points during reassembly, the number of junctions in WAVE2-de-
pleted monolayers was lower than in control monolayers (Figure 7, 
Supplemental Figure S4, and Table 1). When junctions re-formed in 
the WAVE2-depleted monolayers, the fluorescence intensity of the 
tight-junction protein ZO-1 was similar to that in control monolayers 
(Figure 7 and Table 1).
Using a complementary quantitative approach, we measured 
TER on control and WAVE2-depleted monolayers after calcium de-
pletion and repletion (Figure 7B). WAVE2-depleted monolayers had 
a lower initial value for TER, as reported earlier, and they had lower 
TER values under all treatment conditions. However, when the TER 
values were normalized, the rate at which WAVE2-depleted mono-
layers recovered their junctions was similar to that for control mono-
layers. This result is consistent with the observation that ZO-1 levels 
are not altered in WAVE2-depleted junctions.
Taken together, our results show that WAVE2 has an important 
role in promoting the expression or stability of VE-cadherin and its 
recruitment to cell junctions. This role is similar to the role proposed 
for WAVE2 in epithelial cells (Bryce et al., 2013). We conclude that 
the role of WAVE2 in endothelial monolayer integrity is the forma-
tion and maturation of cell–cell junctions.
WAVE2 influences the organization of circumferential 
actin and stress fibers
In addition to lamellar protrusions, ECs contain two other F-ac-
tin-based structures important for monolayer integrity—stress fi-
bers and circumferential actin structures. These structures con-
tain myosin-II, which is contractile, and they are able to create 
tension. In epithelial cells, WAVE2 has been implicated in regu-
lating assembly of circumferential actin (Verma et al., 2012). 
In ECs, circumferential actin is less dense and more loosely 
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FIGURE 7: WAVE2 is important for junction assembly after calcium depletion and addition. (A) Calcium was removed 
from the medium with EGTA to disassemble cadherin-based junctions and then replaced to induce reassembly. Images 
are representative of 5 fov from each of three samples. Scale bar, 50 μm. (B) WAVE2 knockdown causes a defect in 
junctional assembly after calcium addition, based on TER measurements over time. (C) Time course of junction assembly 
revealed by the TER data from B normalized for control and WAVE2-depleted monolayers. The time courses are similar, 
suggesting that junctions recover at a normal rate.
Endothelial WAVE2 controls transmigration of lymphocytes
In an early step in transmigration, docking structures form on the 
surface of ECs; membrane protrusions formed by dynamic actin 
assembly reach up and surround the lymphocyte (Barreiro et al., 
2002; Carman and Springer, 2004; van Buul et al., 2007). Here we 
found that WAVE2 and Arp2/3 complex are recruited to these 
membranes and are necessary to form the protrusions and dock-
ing structures.
WAVE2 has a critical role in docking structure formation, which 
may overlap and synergize with roles of other regulators of Arp2/3 
complex. Dendritic actin network assembly is a multistep process, 
and other proteins likely assist in recruiting and activating Arp2/3 
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WAVE2 promotes and maintains EC junctions by modulating 
actomyosin organization
We also found that WAVE2 was important for the architecture of 
actin–myosin structures in ECs, including circumferential F-actin and 
stress fibers. Resting ECs in monolayers have a loose circumferential 
band of F-actin and myosin-II near the cell edge, which presumably 
helps maintain cell–cell junctions and monolayer integrity. In epithe-
lial cells, cell–cell junctions are associated with a denser band of 
dynamic actin filaments, along with a cortical Arp2/3-based filament 
network (Ivanov and Naydenov, 2013).
Epithelial cells do not have lamellipodia at mature junctions, in 
contrast to our findings here with ECs. In epithelial cells, WAVE2 
localizes to mature cell junctions, where it regulates actin assembly 
(Yamazaki et al., 2007; Verma et al., 2012). In our studies here of 
ECs, WAVE2 and Arp2/3 did not localize to stable cell–cell junc-
tions. Whereas WAVE2 and Arp2/3 complex did localize to the cell 
periphery and to the locations of cell–cell contacts, their localization 
and activity were restricted to junctions that were actively assem-
bling, with lamellipodial membrane protrusions.
Tension is an important parameter that determines the strength of 
the endothelial barrier, one that is highly regulated under resting and 
inflammatory conditions. For epithelial cells, WAVE2 regulates cell 
tension in monolayers by affecting the level of contractile myosin-II, 
the amount of F-actin, and the organization of cortical actin and actin 
fibers at cell junctions (Verma et al., 2012). Our results here with EC 
monolayers also suggest that WAVE2 contributes to cell tension by 
influencing actomyosin organization under both basal and inflamma-
tory conditions. The mechanism for how WAVE2 and Arp2/3-based 
networks contribute to actin fiber organization remains unclear; we 
speculate that branched filaments from Arp2/3-based networks in-
corporate into circumferential filament bundles or stress fibers.
MATERIALS AND METHODS
Cells
Human dermal microvascular ECs from neonates were purchased 
from Lonza (Basel, Switzerland), maintained in EGM-2MV media 
(Lonza), and used between passages 2 and 12. PBLs were collected 
from healthy blood donors (Leukopak; Hemerica, West Warwick, RI) 
and treated as previously described (Carman and Springer, 2004; 
Cernuda-Morollon et al., 2010). PBLs were maintained in culture in 
RPMI with 10% fetal bovine serum (FBS) and interleukin-2 (10 U/ml) 
for 5–10 d before use in experiments.
Reagents and antibodies
Treatment of cells with TNFα (Life Technologies, Frederick, MD) con-
sisted of overnight incubation at 20 ng/ml. S1P (Sigma-Aldrich, St. 
Louis, MO) treatment was at 0.5 μM for 5 min. Anti–ICAM-1 antibod-
ies included mouse BBIG-I1 from R&D Systems (Minneapolis, MN) 
and rabbit H-108 from Santa Cruz Biotechnology (Dallas, TX). 
complex. We found that WAVE2 depletion caused a larger defect in 
the recruitment of F-actin than Arp2/3 complex to docking struc-
tures. We detected N-WASP and cortactin in docking structures, 
confirming previous findings for cortactin (Tilghman and Hoover, 
2002; Yang et al., 2006a). Thus, whereas other regulators may con-
tribute to recruitment of Arp2/3 complex, WAVE2 appears to be 
critical for its activation. In other settings, multiple Arp2/3 regulators 
play complementary and synergistic roles to bind and activate 
Arp2/3 complex for actin nucleation (Padrick et al., 2011; Ti et al., 
2011; Helgeson and Nolen, 2013). Many Arp2/3 regulators possess 
multiple domains for interactions with other proteins, which may 
amplify signals and regulate the assembly of the docking structure.
A second step in lymphocyte transmigration is creation of a 
pore used by the lymphocyte to cross the endothelial monolayer. 
A pore can be created by weakening a junction between two ECs 
(the “paracellular” pathway) or by forming a pore through the in-
terior of one EC (the “transcellular” pathway). We discovered that 
WAVE2 and Arp2/3 complex are critical for the transcellular path-
way. As a transcellular pore develops, the EC controls the size of 
the pore and provides it with structural stability to preserve cell 
viability and integrity. We envision that Arp2/3-based filament net-
works surround the transcellular pore and maintain its size and sta-
bility while the lymphocyte is transmigrating. In addition, many 
membrane-remodeling events occur during transcellular pore 
formation, and Arp2/3 complex and its activators may be impor-
tant for those events.
A third step in transmigration is closure of the pore, returning the 
endothelial monolayer to its original state. We found that, after the 
lymphocyte transmigrates, lamellipodial protrusions form and fill 
the pores, allowing ECs to recreate contacts and cadherin-based 
cell junctions with their neighbors. Actin assembly induced by 
WAVE2 and Arp2/3 complex drives these lamellipodial protrusions.
How cells and layers of cells close gaps, including ones created 
by artificially induced wounds, has been studied in a variety of cell 
and tissue systems. In some cases, closure of the wound involves 
lamellipodial or filopodial protrusions that extend from cells on the 
edge of the wound to create new cell–cell contacts (Bement et al., 
1993; Jacinto et al., 2001; Mattila and Lappalainen, 2008). In epithe-
lial cell layers and in single egg cells, wounds are often closed by a 
contractile purse string of F-actin and myosin-II (Martin and Lewis, 
1992; Bement et al., 1993, 1999; Sonnemann and Bement, 2011). 
Here, in ECs, we found that lamellipodial wave-like protrusions of 
the plasma membrane closed the gaps between cells, consistent 
with results for closing wounds in other endothelial systems 
(Martinelli et al., 2013; Taha et al., 2014). Martinelli et al. (2013) ob-
served that EC lamellipodia closing transcellular wounds were lo-
cated in a ventral position. We did not observe ventral lamellipodia 
in our experiments; however, one can imagine that WAVE2 might 
also promote the formation and movement of those structures.
Parameter Condition No treatment EGTA
Ca2+ addition
30 min 60 min 90 min
Junctions/fov Control 24.8 ± 1.8 6.4 ± 1.6 12.8 ± 2.7 45.3 ± 3.1 42.9 ± 2.0
KD 14.7 ± 2.9* 2.8 ± 0.8 3.9 ± 1.3* 14.3 ± 1.7* 20.5 ± 1.3*
ZO-1 intensity (A.U.) Control 40.5 ± 0.9 21.5 ± 1.4 42.0 ± 2.1 40.7 ± 1.4 73.1 ± 1.7
KD 55.7 ± 1.5* 28.4 ± 2.5* 30.5 ± 3.5 42.2 ± 2.3 66.0 ± 2.7
Standard error is reported for the number of junctions per field of view (fov) and for the ZO-1 fluorescence intensity level in arbitrary units. KD is WAVE2 knockdown. 
Asterisk indicates statistical significance for KD compared with control with p < 0.001.
TABLE 1: WAVE2 is necessary for formation of new junctions.
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(6C5) was from Abcam. Mouse anti–human vinculin monoclonal an-
tibody (hVIN-1) was from Sigma-Aldrich. Rabbit anti–nonmuscle 
myosin heavy chain II-A polyclonal antibody (PRB-440P) was from 
Covance (Emeryville, CA). Secondary antibodies and phalloidin, 
fluorescently conjugated with Alexa dyes, were obtained from 
Molecular Probes (Life Technologies, Eugene, OR).
DNA and siRNAs
Human cDNA encoding WAVE2 fused at its C-terminus to GFP was 
a gift from Tadaomi Takenawa (Kobe University, Kobe, Japan). The 
WAVE2 coding region from that plasmid was subcloned into the 
Antibodies to VE-cadherin included a monoclonal mouse anti–hu-
man CD144 antibody (clone 55-7H1; BD Biosciences, San Jose, CA) 
and a polyclonal rabbit anti–human VE-cadherin antibody (#2158; 
Cell Signaling, Danvers, MA). Anti-GFP was a rabbit polyclonal 
(ab6556; Abcam, Cambridge, MA). Anti-Arp3 was either a mouse 
anti–human monoclonal (FMS338; Sigma-Aldrich, St. Louis, MO) or 
a rabbit anti–bovine polyclonal (Welch et al., 1997)). Rabbit anti–
human WAVE-2 monoclonal antibody (D2C8, #3659) was from Cell 
Signaling. Mouse anti–human ZO-1 monoclonal antibody (ZO-
-1A12) was from Invitrogen (Camarillo, CA). Mouse anti–human 
glyceraldehyde-3-phosphate dehydrogenase monoclonal antibody 
FIGURE 8: WAVE2 controls the organization of actin-myosin fibers in ECs. Areas with well-spread cells were selected to 
reveal circumferential actin–myosin rings and stress fibers. (A) Control and WAVE2-knockdown endothelial monolayers 
stained for F-actin and myosin-IIA. Scale bar, 50 μm. (B) Line scans across representative actin–myosin rings in control 
and WAVE2-depleted cells. (C) WAVE2 influences changes in circumferential actin rings and stress fibers induced by 
TNFα. Arrows indicate the circumferential to linear change in actin organization that results from TNFα. When WAVE2 is 
depleted, circumferential actin is increased and stress fibers are decreased with and without TNFα. Scale bar, 50 μm.
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Germany) using a 40×/1.2 numerical aperture (NA) water immersion 
objective. Wide-field fluorescence images were collected using an 
inverted microscope (Olympus IX-81; Olympus, Center Valley, PA) 
with a 40×/0.75 NA objective, a Hg-lamp light source and a Hama-
matsu electron-multiplying charge-coupled device video camera 
(Hamamatsu, Bridgewater, NJ).
Live-cell movies, with fluorescence and differential interference 
contrast (DIC) optics, were collected on a Zeiss 510 LSM equipped 
with a CO2- and temperature-controlled stage insert (Tokai Hit, 
Shizuoka-ken, Japan). Movies were also collected on an inverted 
microscope (Olympus IX73) equipped with a CoolSnap HQ video 
camera (Photometrics, Tucson, AZ) and the same stage insert. 
Movies were collected with a 10×/0.25 NA phase objective or a 
40×/0.75 NA objective.
Transwell assay for transmigration
HDMVECs were seeded at 3 × 104 cells/well in a 24-well Transwell 
dish (3-μm pore size; Corning, Fisher Scientific). Inserts were coated 
with 15 μg/ml fibronectin (Sigma-Aldrich) before seeding. Cells were 
cultured on Transwell for 48 h before experiments, with 20 ng/ml 
TNFα added for 4 h before addition of PBLs.
At time zero, TNFα-containing medium was removed from the 
Transwell chambers, 1.5 × 105 PBLs in regular HDMVEC medium 
were added to the top chamber, and medium with SDF1α (30 ng/
ml) was added to the bottom chamber. PBLs were allowed to mi-
grate across the Transwell at 37°C for 1 h. Cells were collected from 
the bottom chamber and counted using a hemocytometer.
Docking structure formation and staining
Anti-ICAM antibodies (rabbit or mouse, described earlier) were 
coupled to polystyrene beads (10 μm; Polysciences, Warrington, 
PA) per the manufacturer’s recommendations. Anti-ICAM–coated 
beads were incubated with TNFα-treated HDMVECs (20 ng/ml 
TNFα, overnight) for 30 min at 37°C. To visualize the localization of 
F-actin and Arp2/3 complex to the anti-ICAM bead and docking 
structure, we stained cells with fluorescent phalloidin and antibod-
ies, as described earlier. A z-series of images was collected with a 
laser-scanning confocal microscope (Zeiss LSM510). The images 
were scored for the presence of rings of F-actin or Arp2/3 complex 
around the beads.
In control experiments, beads coated with nonspecific anti–
mouse or anti–rabbit immunoglobulin G did not adhere to TNFα-
treated endothelial monolayers. In addition, the number of beads 
adhering to the cells and the number of docking structures were 
much less if ECs were not treated with TNFα, which increases the 
level of cell-surface ICAM-1 (Pober et al., 1986; Dustin and Springer, 
1988; Detmar et al., 1990; Yang et al., 2005).
Transendothelial resistance
HDMVECs were plated on fibronectin-coated Transwells as de-
scribed and grown to confluence. Resistance across the Transwell 
filter was measured with an EVOM-2 m and an Endohm-6 electrode 
adapter (World Precision Instruments, Sarasota, FL). TER was calcu-
lated by subtracting the resistance of a blank well from that of the 
sample well and multiplying that difference by the surface area of 
the filter. The TER index was calculated by normalizing the TER val-
ues on a scale from 0 to 1, with 0 as the value for LatA treatment and 
1 as the value for control monolayers.
Quantitation of the route of transmigration
HDMVECs were plated to confluence on fibronectin-coated poly-
acrylamide (PA) gels (Onken, Mooren, Mukherjee, Shahan, Li, and 
pBOB-GFP lentiviral vector (gift of George Bloom, University of Vir-
ginia, Charlottesville, VA). Lentivirus carrying the pBOB-GFP-WAVE2 
plasmid were generated as described later. For expression of mem-
brane-tagged GFP, plasmid 14757 was obtained from Addgene 
(Matsuda and Cepko, 2007).
siRNAs were obtained from Dharmacon (Thermo Scientific, Pitts-
burgh, PA). First, a pool of four siRNAs targeting human WAVE2 
(ON-TARGETplus SMARTpools for WASF2) was tested to assess 
phenotype. Next individual siRNAs from that pool were tested. The 
oligonucleotide (GGAUUUGGGUCUCCAGGGA) that produced the 
largest decrease in WAVE2 expression (∼80–85%, based on immuno-
blots; Supplemental Figure S1A) was chosen for subsequent studies. 
Off-target siRNA effects were excluded by demonstration of rescue 
of WAVE2-knockdown phenotypes by expression of WAVE2 from 
siRNA-resistant full-length cDNA constructs with six codon-neutral 
point mutations (GGcTTcGGcTCaCCgGGaA). Cells were transfected 
using Lipofectamine RNAiMAX transfection reagent (Invitrogen).
Lentivirus production
Human WAVE2-GFP and plain GFP, as a control, were expressed 
in HDMVECs by lentiviral transduction. Lentivirus was produced 
by transfecting a 6-cm dish of HEK293T cells with 4.8 μg of DNA, 
including pBOB-GFP (2 μg), pMDL/PRRE (1.45 μg), pVSVG 
(0.8 μg), and pRSV-rev (0.55 μg). Transfection was performed with 
TransIT-LT1 (Mirus, Madison, WI) in low-antibiotic HEK293T cul-
ture medium (DMEM, 10% FBS, 0.1× penicillin/streptomycin [pen/
strep]). The medium was changed on the next day to DMEM with 
30% FBS and 1× pen/strep. Media containing virus was collected 
48 h posttransfection and concentrated by ultracentrifugation. 
For viral transduction, HDMVEC cells were incubated with lentivi-
rus overnight in the presence of 10 μg/ml protamine sulfate.
Permeability assays
Permeability assays were performed by adding 40-kDa fluorescein 
isothiocyanate–dextran (gift from Robyn Klein, Washington Univer-
sity, St. Louis, MO) to the top chamber of a Transwell device. After 1 h, 
fluorescence was measure in medium collected from the bottom cham-






In this equation, V is the volume of the receiving chamber, SA is the 
surface area, CD is the concentration of tracer in the donor chamber 
at time zero, and CR is the concentration of tracer in the receiving 
chamber at time T. CR was calculated from fluorescence intensity. 
Permeability index was calculated by normalizing PC values on a 
scale from 0 to 1, with 0 defined as the value for control monolayers 
and 1 as the value for the Transwell membrane alone without ECs.
Staining of cells with fluorescent antibodies and phalloidin
In most cases, cells were fixed with paraformaldehyde, permeabi-
lized, and incubated with primary and secondary antibodies as de-
scribed (Mooren et al., 2009). In some cases, the fixative was trichlo-
roacetic acid (TCA); cells were treated with ice-cold 10% TCA for 
15 min. Fluorescent phalloidin was added to secondary antibody 
solution in some cases. Coverslips were mounted in Vectashield 
(H1000; Vector Laboratories, Burlingame, CA) or ProLong Gold (Life 
Technologies, Grand Island, NY).
Light microscopy
For immunofluorescence, a set of z-stack images was collected with 
a laser-scanning confocal microscope (Zeiss 510 LSM; Zeiss, Jena, 
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Cooper, unpublished data. Coverslips were functionalized by 
silanization for 3 min using aminosilane (Sigma-Aldrich). Next 
the coverslips were treated for 30 min with 0.5% glutaraldehyde 
(Sigma-Aldrich). PA gels were made by using a mixture of 7% acryl-
amide and 3% (3-acrylamidopropyl) trimethylammonium chloride 
(Sigma-Aldrich) in phosphate-buffered saline. To vary the polymer 
stiffness, 0.4% bis-acrylamide was added. Next 0.1% APS (ammo-
nium persulfate; Sigma-Aldrich) and 0.1% TEMED (N,N,N′,N′-
tetramethylethylenediamine; Sigma-Aldrich) were added to the 
mixture to initiate polymerization. This gel mixture was placed as a 
large droplet on the functionalized coverslip. A nonfunctionalized 
glass coverslip was placed on top of the gel mixture to sandwich the 
liquid between the two coverslips to create a thin, flat gel. PA gels 
were polymerized for ∼30 min before coating with fibronectin. Addi-
tion of 0.4% bis-acrylamide resulted in a ∼50-kPa stiffness (Tse and 
Engler, 2010), which produced the highest number of transcellular-
route migration events compared with glass and PA gels of higher 
or lower stiffness (Onken et al., unpublished data).
PBLs were added to confluent EC monolayers on PA gels for 
15 min before fixation. Samples were processed for immunofluo-
rescence and stained for VE-cadherin, ICAM-1, and F-actin in or-
der to reveal the route of PBL transmigration. Events were 
counted by a variety of methods, but at least 15 fields of view 
were counted per dish. The percentage of cells was calculated by 
the total number of events divided by the total number of PBLs 
counted. The p values were calculated using a 2 × 2 contingency 
table and Fisher’s exact test.
Quantitation of F-actin, myosin-IIA, and VE-cadherin
F-actin cytoskeletons were prepared from HDMVEC cells by treat-
ment with 0.01% saponin and 0.07 μM phalloidin in 60 mM 1,4-pip-
erazinediethanesulfonic acid, 25 mM 4-(2-hydroxyethyl)-1-pipera-
zineethanesulfonic acid, 10 mM EGTA, and 2 mM MgCl2, pH 6.9, for 
3 min at 37°C. Cells were washed twice, and then hot 1× SDS sam-
ple buffer (50 mM Tris/HCl, pH 6.8, 4% SDS, 0.1% bromophenol 
blue, 10% glycerol, 5% β-mercaptoethanol) was added. SDS–PAGE 
and anti-actin immunoblots were performed. For myosin-IIA, cor-
rected total cell fluorescence was calculated from immunofluores-
cence images as described (Burgess et al., 2010). For VE-cadherin, 
line scans with a width of 7 μm were prepared from representative 
portions of immunofluorescence images with ImageJ (National Insti-
tutes of Health, Bethesda, MD).
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